Salem Mohamed Labib
Department of Surgery, Section of Surgical Oncology, Holling Cancer Center R313, Medical University of South Carolina, Charleston, SC 29425, USA.
Int Immunopharmacol. 2005 Jun;5(6):947-60. doi: 10.1016/j.intimp.2004.12.013. Epub 2005 Jan 25.
Recently, there has been a great interest in the effects of different types of n-6 polyunsaturated acids (n-6 PUFAs) upon the immune system and cancer development. However, the effects of n-6 PUFAs are still controversial and as yet undefined. The present study aimed to investigate the anti-tumor effects of n-6 PUFAs against EL4 thymoma and the associated immune mechanisms. To this, sesame oil, a vegetable oil enriched with n-6 PUFAs, or free linoleic acid (LA) were administered intraperitoneally into C57BL/6 mice before and after challenge with EL4 lymphoma cells. Treatment with either sesame oil or LA attenuated the growth and metastasis of EL4 lymphoma. The anti-tumor effect of LA was superior to that of sesame oil, and associated with an increase in the survival rate of the tumor-bearing mice. In addition, both sesame oil and LA showed dose-dependent anti-lymphoma growth in vitro. Treatment with LA generated significant increases in the anti-lymphoma cytolytic and cytostatic activities of T cells and macrophages, respectively, and enhanced production of IL-2 and IFN-gamma while decreased production of IL-4, IL-6 and IL-10. In summation, the results suggest that n-6 PUFAs, represented by LA, can attenuate EL4 lymphoma growth and metastasis through enhancing the specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. These findings might be of great importance for a proper design of systemic nourishment with PUFAs emulsions for cancer patients.
最近,人们对不同类型的n-6多不饱和脂肪酸(n-6 PUFAs)对免疫系统和癌症发展的影响产生了浓厚兴趣。然而,n-6 PUFAs的影响仍存在争议且尚未明确。本研究旨在探讨n-6 PUFAs对EL4胸腺瘤的抗肿瘤作用及相关免疫机制。为此,在EL4淋巴瘤细胞攻击前后,将富含n-6 PUFAs的植物油芝麻油或游离亚油酸(LA)腹腔注射到C57BL/6小鼠体内。芝麻油或LA处理均能减轻EL4淋巴瘤的生长和转移。LA的抗肿瘤作用优于芝麻油,并与荷瘤小鼠存活率的提高有关。此外,芝麻油和LA在体外均表现出剂量依赖性的抗淋巴瘤生长作用。LA处理分别显著提高了T细胞和巨噬细胞的抗淋巴瘤溶细胞和细胞毒活性,并增强了IL-2和IFN-γ的产生,同时降低了IL-4、IL-6和IL-10的产生。总之,结果表明以LA为代表的n-6 PUFAs可通过增强特异性和非特异性抗肿瘤溶细胞活性以及TH1细胞因子的产生来减轻EL4淋巴瘤的生长和转移。这些发现对于合理设计用于癌症患者的PUFAs乳剂全身营养方案可能具有重要意义。